Related scientific articles (all)

Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis.

Authors : Ignatiadis M, Singhal SK, Desmedt C, Haibe-Kains B, Criscitiello C, Andre F, Loi S, Piccart-Gebhart M, Michiels S, Sotiriou C
Year : 2012
Journal : J. Clin. Oncol.
Volume : 30(16)
Pages : 1996-2004

Neoadjuvant chemotherapy with HER2 inhibitors for breast cancer - Authors' reply.

Authors : Baselga J, de Azambuja E, Bradbury I, Gelber R
Year : 2012
Journal : Lancet
Volume : 379 (9833)
Pages : 2238

Role of Epac and protein kinase A in thyrotropin-induced gene expression in primary thyrocytes.

Authors : van Staveren WC, Beeckman S, Tomás G, Dom G, Hébrant A, Delys L, Vliem MJ, Trésallet C, Andry G, Franc B, Libert F, Dumont JE, Maenhaut C
Year : 2012
Journal : Exp. Cell Res.
Volume : 318(5)
Pages : 444-52

Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911).

Authors : Bolla M, Van Poppel H, Tombal B, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, Van Velthoven R, Colombel M, van de Beek C, Verhagen P, Van den Bergh A, Sternberg C, Gasser T, Van Tienhoven G, Scalliet P, Haustermans K, Collette L
Year : 2012
Journal : Lancet
Volume : 380(9858)
Pages : 2018-27

Esophageal self-expanding metallic stent (SEMS) migration: it's a topsy-turvy world.

Authors : Toussaint E, Zalcman M, Devière J, Le Moine O, Arvanitakis M
Year : 2012
Journal : Endoscopy
Volume : 44 Suppl 2
Pages : E352-3

A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours.

Authors : Schöffski P, Awada A, Dumez H, Gil T, Bartholomeus S, Wolter P, Taton M, Fritsch H, Glomb P, Munzert G
Year : 2012
Journal : Eur. J. Cancer
Volume : 48(2)
Pages : 179-86

Molecular biology in breast cancer: Should molecular classifiers be assessed by conventional tools or by gene expression arrays?

Authors : Fumagalli D, Andre F, Piccart-Gebhart M, Sotiriou C, Desmedt C
Year : 2012
Journal : Crit Rev Oncol Hematol
Volume : 84 supl 1
Pages : e58-69

Cancer du sein et radiothérapie peropératoire par électrons (IOERT)

Authors : Philippson C, Nogaret JM
Year : 2012
Journal : Gynécologie EMC
Volume : 7(4)
Pages : 1-8

Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries.

Authors : Saini KS, Taylor C, Ramirez AJ, Palmieri C, Gunnarsson U, Schmoll HJ, Dolci SM, Ghenne C, Metzger-Filho O, Skrzypski M, Paesmans M, Ameye L, de Azambuja E, Piccart-Gebhart M
Year : 2012
Journal : Ann Oncol
Volume : 23(4)
Pages : 853-859

Bone metastasis in breast cancer: The story of RANK-Ligand.

Authors : Azim HA, Kamal NS
Year : 2012
Journal : J Egypt Natl Canc Inst
Volume : 24(3)
Pages : 107-14

Has removal of excess cysteine led to the evolution of pheomelanin? Pheomelanogenesis as an excretory mechanism for cysteine.

Authors : Galván I, Ghanem G, Møller AP
Year : 2012
Journal : Bioessays
Volume : 34(7)
Pages : 565-8

Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T.

Authors : Lagemaat MW, Zechmann CM, Fütterer JJ, Weiland E, Lu J, Villeirs GM, Holshouser BA, van Hecke P, Lemort M, Schlemmer HP, Barentsz JO, Roell SO, Heerschap A, Scheenen TW
Year : 2012
Journal : J Magn Reson Imaging
Volume : 35(1)
Pages : 166-73

Milestones in the use of chemotherapy for the management of non-small cell lung cancer (NSCLC).

Authors : Klastersky J, Awada A
Year : 2012
Journal : Crit Rev Oncol Hematol
Volume : 81(1)
Pages : 49-57

Next-generation sequencing in breast cancer: first take home messages.

Authors : Desmedt C, Voet T, Sotiriou C, Campbell PJ
Year : 2012
Journal : Curr Opin Oncol
Volume : 24(6)
Pages : 597-604

Exploitation de la spectrométrie de masse en microbiologie : une révolution.

Authors : Martiny D, Vandenberg O
Year : 2012
Journal : J immbio
Volume : 27(4)
Pages : 177-84

EORTC 24051: Unexpected side effects in a phase I study of TPF induction chemotherapy followed by chemoradiation with lapatinib, a dual EGFR/ErbB2 inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell carcinoma.

Authors : Lalami Y, Specenier PM, Awada A, Lacombe D, Liberatoscioli C, Fortpied C, El-Hariry I, Bogaerts J, Andry G, Langendijk HJ, Vermorken JB
Year : 2012
Journal : Radiother Oncol
Volume : 105(2)
Pages : 238-40

Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies.

Authors : Azim HA, Santoro L, Russell-Edu W, Pentheroudakis G, Pavlidis N, Peccatori FA
Year : 2012
Journal : Cancer Treat Rev
Volume : 38(7)
Pages : 834-42

MDM4 is a key therapeutic target in cutaneous melanoma.

Authors : Gembarska A, Luciani F, Fedele C, Russell EA, Dewaele M, Villar S, Zwolinska A, Haupt S, de Lange J, Yip D, Goydos J, Haigh JJ, Haupt Y, Larue L, Jochemsen A, Shi H, Moriceau G, Lo RS, Ghanem G, Shackleton M, Bernal F, Marine JC
Year : 2012
Journal : Nat. Med.
Volume : 18
Pages : 1239-47

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.

Authors : Baselga J, Campone M, Piccart-Gebhart M, Burris HA, Rugo HS, Sahmoud T, Noguchi S, Gnant M, Pritchard KI, Lebrun F, Beck JT, Ito Y, Yardley D, Deleu I, Perez A, Bachelot T, Vittori L, Xu Z, Mukhopadhyay P, Lebwohl D, Hortobagyi GN
Year : 2012
Journal : N Engl J Med
Volume : 366(6)
Pages : 520-9

Treatment Options in Anthracycline and/or Taxane Pretreated Patients with Metastatic Breast Cancer.

Authors : Pugliano L, de Azambuja E
Year : 2012
Journal : Onkologie
Volume : 35(9)
Pages : 476-8